Publications
Filters: Keyword is Animals, Genetically Modified [Clear All Filters]
Renoprotective effects of neuronal NOS-derived nitric oxide and cyclooxygenase-2 metabolites in transgenic rats with inducible malignant hypertension. Am J Physiol Renal Physiol. 2008;294(1):F205-11. Abstract
Renal vascular and tubulointerstitial inflammation and proliferation in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension. Am J Physiol Renal Physiol. 2007;292(6):F1858-66. Abstract
Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension. Am J Physiol Renal Physiol. 2006;291(3):F612-8. Abstract
Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats. J Renin Angiotensin Aldosterone Syst. 2006;7(2):74-86. Abstract
alphaV integrins are necessary for eutrophic inward remodeling of small arteries in hypertension. Hypertension. 2006;47(2):281-7. Abstract
Genetic basis of hypertension. The renin-angiotensin paradigm. Hypertension. 1991;18(5 Suppl):III109-14.
Transgenic rats: new animal models in hypertension research. Invited lecture. Hypertension. 1991;17(6 Pt 2):843-55.


]